1. Home
  2. RVPH vs CHSN Comparison

RVPH vs CHSN Comparison

Compare RVPH & CHSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • CHSN
  • Stock Information
  • Founded
  • RVPH 2006
  • CHSN 2009
  • Country
  • RVPH United States
  • CHSN China
  • Employees
  • RVPH N/A
  • CHSN N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • CHSN Packaged Foods
  • Sector
  • RVPH Health Care
  • CHSN Consumer Staples
  • Exchange
  • RVPH Nasdaq
  • CHSN Nasdaq
  • Market Cap
  • RVPH 36.4M
  • CHSN 36.1M
  • IPO Year
  • RVPH N/A
  • CHSN 2023
  • Fundamental
  • Price
  • RVPH $1.15
  • CHSN $1.90
  • Analyst Decision
  • RVPH Strong Buy
  • CHSN
  • Analyst Count
  • RVPH 3
  • CHSN 0
  • Target Price
  • RVPH $14.33
  • CHSN N/A
  • AVG Volume (30 Days)
  • RVPH 165.3K
  • CHSN 53.1K
  • Earning Date
  • RVPH 08-12-2024
  • CHSN 07-23-2024
  • Dividend Yield
  • RVPH N/A
  • CHSN N/A
  • EPS Growth
  • RVPH N/A
  • CHSN N/A
  • EPS
  • RVPH N/A
  • CHSN 0.00
  • Revenue
  • RVPH N/A
  • CHSN $17,252,662.00
  • Revenue This Year
  • RVPH N/A
  • CHSN N/A
  • Revenue Next Year
  • RVPH N/A
  • CHSN N/A
  • P/E Ratio
  • RVPH N/A
  • CHSN $630.00
  • Revenue Growth
  • RVPH N/A
  • CHSN 17.44
  • 52 Week Low
  • RVPH $1.05
  • CHSN $1.10
  • 52 Week High
  • RVPH $6.80
  • CHSN $18.65
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 37.66
  • CHSN 34.04
  • Support Level
  • RVPH $1.17
  • CHSN $1.88
  • Resistance Level
  • RVPH $1.24
  • CHSN $2.06
  • Average True Range (ATR)
  • RVPH 0.10
  • CHSN 0.20
  • MACD
  • RVPH 0.03
  • CHSN -0.11
  • Stochastic Oscillator
  • RVPH 39.17
  • CHSN 3.42

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About CHSN Chanson International Holding

Chanson International Holding manufactures and sells a wide selection of bakery products, seasonal products, and beverage products; some of these stores also offer eat-in services. It focuses to make healthy, nutritious, and ready-to-eat food through advanced facilities and industry research and to create a comfortable, yet distinguishable store environment in which customers can enjoy their products.

Share on Social Networks: